J. Olson

Tissue Disposition of 5‐o‐Carboranyluracil—A Novel Agent for the Boron Neutron Capture Therapy of Prostate Cancer

R. Schinazi, S. Hurwitz, T. Keane, 2004, Nucleosides, nucleotides & nucleic acids.

ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449

Susan M. Chang, A. Sloan, A. Norden, 2022, Journal of Neuro-Oncology.

Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.

J. Shi, R. Schinazi, S. Hurwitz, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Susan M. Chang, A. Friedman, J. Olson, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Selective killing of cancer cells based on loss of heterozygosity and normal variation in the human genome: a new paradigm for anticancer drug therapy.

D. Housman, J. Basilion, V. Stanton, 1999, Molecular pharmacology.

Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS

A. Asher, K. Patel, S. Burri, 2023, Research Square.